NHS-IL12 for Solid Tumors
NCT01417546
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
NIH
Sponsor class
Conditions
Epithelial Neoplasms, Malignant
Epithelial Tumors, Malignant
Malignant Mesenchymal Tumor
Interventions
DRUG:
NHS-IL-12
Sponsor
National Cancer Institute (NCI)